ZNF713
Zinc finger protein 713
Also known as: FLJ39963, ZN713_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N859
- Gene
- ZNF713
- Ensembl
- ENSG00000178665
- Chromosome
- 7
- Canonical length
- 443 aa
- Protein class
- Disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoli
OverviewNCBI Gene
The protein encoded by this gene contains C2H2 zinc finger domains. In some individuals, a CGG-repeat expansion from 5-22 repeats to 68-450 repeats has been identified in the first intron of this gene. This mutation is thought to effect the expression of this gene and it has been proposed that it may be associated with Autistic Spectrum Disorder. [provided by RefSeq, Jul 2016]
Canonical amino-acid sequenceUniProt
443 residues, UniProt reviewed canonical sequence.
>Q8N859|ZNF713
1 MPSQNAVFSQ EGNMEEEEMN DGSQMVRSQE SLTFQDVAVD FTREEWDQLY PAQKNLYRDV
61 MLENYRNLVA LGYQLCKPEV IAQLELEEEW VIERDSLLDT HPDGENRPEI KKSTTSQNIS
121 DENQTHEMIM ERLAGDSFWY SILGGLWDFD YHPEFNQENH KRYLGQVTLT HKKITQERSL
181 ECNKFAENCN LNSNLMQQRI PSIKIPLNSD TQGNSIKHNS DLIYYQGNYV RETPYEYSEC
241 GKIFNQHILL TDHIHTAEKP SECGKAFSHT SSLSQPQMLL TGEKPYKCDE CGKRFSQRIH
301 LIQHQRIHTG EKPFICNGCG KAFRQHSSFT QHLRIHTGEK PYKCNQCGKA FSRITSLTEH
361 HRLHTGEKPY ECGFCGKAFS QRTHLNQHER THTGEKPYKC NECGKAFSQS AHLNQHRKIH
421 TREKLCEYKC EQTVRHSPSF SSTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF713 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 3.5 nTPM
Expression across tissuesHPA
Tissue
- testis: 3.5 nTPM
- cerebral cortex: 2.3 nTPM
- retina: 2.2 nTPM
- fallopian tube: 1.7 nTPM
- ovary: 1.6 nTPM
- skeletal muscle: 1.6 nTPM
Single-cell type
- ependymal cells: 59 nCPM
- oligodendrocytes: 47 nCPM
- choroid plexus epithelial cells: 43 nCPM
- oligodendrocyte progenitor cells: 30 nCPM
- brain inhibitory neurons: 29 nCPM
- bergmann glia: 26 nCPM
Immune cell
- neutrophil: 2.8 nTPM
- basophil: 1.7 nTPM
- eosinophil: 1.5 nTPM
- naive B-cell: 0.5 nTPM
- NK-cell: 0.4 nTPM
- classical monocyte: 0.3 nTPM
Brain region
- white matter: 18 nTPM
- medulla oblongata: 13 nTPM
- pons: 13 nTPM
- cerebellum: 13 nTPM
- cerebral cortex: 13 nTPM
- thalamus: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.04
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.01
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF713 as an antibody target. Whether an autoantibody or antibody against ZNF713 could matter depends on whether native ZNF713 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF713 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF713 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...